Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Cagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in obese male rats
Nature metabolism, 2026
Efficacy and Safety of CagriSema for Metabolic Outcomes: Systematic Review and Pairwise Meta-Analysis of Randomized Controlled Trials
Diabetes, metabolic syndrome and obesity : targets and therapy, 2026;19:616418
The Role of the OSM/OSMRβ Axis in Chronic Liver Disease Progression and Hepatocellular Carcinoma Development: A Focus on MASLD/MASH
International journal of molecular sciences, 2026;27(18)
GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Pediatric Obesity: From Neuroendocrine Mechanisms to Clinical Application
International journal of molecular sciences, 2026;27(18)
Beauty standards and reproductive health: increasing use of GLP-1 receptor agonists despite limited evidence
Frontiers in endocrinology, 2026;17:1911235
Weight Reduction Heterogenicity and Mediators of GLP-1RAs and Dual Agonists for Individuals With Obesity: A Meta-Analysis
Clinical obesity;16(5):e70112
GLP-1 receptor agonist use and mental health outcomes in adolescents with obesity: a retrospective review
Journal of pediatric endocrinology & metabolism : JPEM, 2026
DUTCH weight control in atrial fibrillation study (DUTCH-WAIST) : Design and rationale of a randomised controlled trial
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2026
Obstructive sleep apnea, GLP-1 receptor agonist pharmacotherapy, and the oral microbiome: competing biological influences and implications for oral health monitoring
Clinical oral investigations, 2026;30(10)
Effects of GLP-1 receptor agonists on body weight and cardiovascular outcomes: a review
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2026
Real-World Evidence for Existing Anti-Obesity Therapies-The Realities of Treatment Adherence, Tolerability, Access and Patient Satisfaction
Diabetes, obesity & metabolism, 2026
Potential Associations Between GLP-1 Receptor Agonists and Polyendocrine Metabolic Ovarian Syndrome: Triangulation of Genetic and Pharmacovigilance Evidence
Diabetes, obesity & metabolism, 2026
Psychiatric Safety of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Adolescents With Obesity
Diabetes, obesity & metabolism, 2026
Prior GLP-1RA or Tirzepatide Use and Early Cardiorenal Outcomes After Metabolic and Bariatric Surgery
The American journal of medicine, 2026
GLP-1 receptor agonists, epigenetic aging, and the prospect of pharmacological healthspan extension
Experimental gerontology, 2026;:113325
Anaphylaxis to Tirzepatide Confirmed by Positive Skin Prick Testing
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2026
Semaglutide in postmenopausal women: Clinical implications for weight loss, muscle health, and sleep-disordered breathing
Maturitas, 2026;214:109129
Modern Obesity Treatment: Efficacy, Safety, and Future Directions of GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) Receptor Agonists
Cureus, 2026;18(9):e116245
Association of GLP-1-based therapy with asthma-related outcomes in patients with obesity: a propensity-matched retrospective cohort study
Expert review of respiratory medicine, 2026
GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis
Drugs, 2026